Evidence map›Paper›PMID 25908735›Full record

ArticleJournal of leukocyte biology2015

Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.

Hiroshi Itoh, Hidemasa Matsuo, Naoko Kitamura, Sho Yamamoto, Takeshi Higuchi, Hiromu Takematsu, Yasuhiko Kamikubo, Tadakazu Kondo, Kouhei Yamashita, Masataka Sasada and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Neutrophils: a new target for postoperative cognitive dysfunction.Apoptosis : an international journal on programmed cell death · 2025
    Review
  4. Effects of neutrophil fate on inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Neutrophils: Many Ways to Die.Frontiers in immunology · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Autophagy in neutrophils.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2020
    Review
  15. Review
  16. Pediatric subset of primary immunodeficiency patients treated with SCIG: post hoc analysis of SHIFT and IBIS pooled data.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Autophagy and inflammation.Clinical and translational medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hiroshi ItohDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Hidemasa MatsuoDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Naoko KitamuraDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Sho YamamotoDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Takeshi HiguchiDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Hiromu TakematsuDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Yasuhiko KamikuboDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Tadakazu KondoDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Kouhei YamashitaDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Masataka SasadaDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Akifumi Takaori-KondoDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan.
Souichi AdachiDepartments of *Human Health Sciences and Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan; and Department of Hematology and Oncology, Shiga Medical Center for Adults, Shiga, Japan adachiso@kuhp.kyoto-u.ac.jp.
Kyoto University · JPKyoto University Hospital · JPShiga Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy occurs in human neutrophils after the phagocytosis of multidrug-resistant bacteria and drug-sensitive strains, including Escherichia coli and Pseudomonas aeruginosa. The present study detected autophagy by immunoblot analysis of LC3B conversion, by confocal scanning microscopic examination of LC3B aggregate formation and by transmission electron microscopic examination of bacteria-containing autophagosomes. Patients with severe bacterial infections are often treated with IVIG alongside antimicrobial agents. Here, we showed that IVIG induced neutrophil-mediated phagocytosis of multidrug-resistant strains. Compared with untreated neutrophils, neutrophils exposed to IVIG showed increased levels of bacterial cell killing, phagocytosis, O(2)(-) release, MPO release, and NET formation. IVIG also increased autophagy in these cells. Inhibiting the late phase of autophagy (fusion of lysosomes with autophagosomes) with bafilomycin A1-reduced, neutrophil-mediated bactericidal activity. These findings indicate that autophagy plays a critical role in the bactericidal activity mediated by human neutrophils. Furthermore, the autophagosomes within the neutrophils contained bacteria only and their organelles only, or both bacteria and their organelles, a previously undocumented observation. Taken together, these results suggest that the contents of neutrophil autophagosomes may be derived from specific autophagic systems, which provide the neutrophil with an advantage. Thus, IVIG promotes the neutrophil-mediated killing of multidrug-resistant bacteria as well as drug-sensitive strains.

Indexed as

AutophagyDrug Resistance, Multiple, BacterialBacteriaBlood Bactericidal ActivityHumansImmunoglobulins, IntravenousMacrolidesNeutrophilsPeroxidaseSuperoxidesbafilomycin A1Immunoglobulins, IntravenousMacrolidesPeroxidaseSuperoxidesbactericidal activityNETsphagocytosisxenophagy

Identifiers

PMID25908735
PMCPMC4467167
OpenAlexW2120909416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.